Germacrone: A Multi-targeting Sesquiterpene with Promising Anti-cancer and Chronic Disease Applications
- PMID: 39113300
- DOI: 10.2174/0118715206312324240805075050
Germacrone: A Multi-targeting Sesquiterpene with Promising Anti-cancer and Chronic Disease Applications
Abstract
Background: Germacrone, a naturally occurring active compound found in essential oils extracted from medicinal plants within the Zingiberaceae family, has garnered attention for its potential therapeutic applications. Extensive research has highlighted its multi-targeting capabilities, positioning it as a promising treatment for various chronic diseases, including cancer, cardiovascular conditions, and neurodegenerative disorders like Alzheimer's disease.
Objective: This review aims to provide a comprehensive overview of germacrone as a scaffold for developing multi-targeting drugs with therapeutic potential against a range of chronic disorders. The study delves into the molecular mechanisms that underlie the therapeutic effects of germacrone and explores its potential targets, including NF-κB, PI3K/AKT/mTOR, p53, JAK/STAT, caspase, apoptosis, and autophagy induction.
Methods: A systematic review of literature databases was conducted to gather relevant studies on germacrone and its therapeutic applications. The molecular mechanisms and potential targets of germacrone were examined to elucidate its multi-targeting capabilities.
Results: Germacrone exhibits significant potential in the management of chronic diseases, with demonstrated effects on various cellular pathways. The review highlights its impact on NF-κB, PI3K/AKT/mTOR, p53, JAK/STAT, caspase, apoptosis, and autophagy induction, showcasing its versatility in targeting multiple pathways associated with chronic conditions. Germacrone has emerged as a promising candidate for the treatment of diverse chronic diseases. The understanding of its multi-targeting capabilities, coupled with its natural origin, positions it as a valuable scaffold for developing therapeutics.
Conclusion: The exploration of germacrone as a structural framework for multi-targeting drugs offers a potential avenue to enhance efficacy while minimizing potential side effects. Further research and clinical trials are warranted to validate the therapeutic potential of germacrone in diverse medical contexts.
Keywords: Anti-cancer activity; chronic diseases; germacrone; multi-targeting therapy; natural compounds; therapeutic applications..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Germacrone exerts anti-cancer effects on gastric cancer through induction of cell cycle arrest and promotion of apoptosis.BMC Complement Med Ther. 2020 Jan 23;20(1):21. doi: 10.1186/s12906-019-2810-3. BMC Complement Med Ther. 2020. PMID: 32020876 Free PMC article.
-
Germacrone: A Potent Secondary Metabolite with Therapeutic Potential in Metabolic Diseases, Cancer and Viral Infections.Curr Drug Metab. 2020;21(14):1079-1090. doi: 10.2174/1389200221999200728144801. Curr Drug Metab. 2020. PMID: 32723267 Review.
-
Germacrone Inhibits Cell Proliferation and Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cells.Biomed Res Int. 2020 Jan 30;2020:7643248. doi: 10.1155/2020/7643248. eCollection 2020. Biomed Res Int. 2020. PMID: 32071920 Free PMC article.
-
Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis.Eur J Pharmacol. 2011 Sep 30;667(1-3):50-5. doi: 10.1016/j.ejphar.2011.03.041. Epub 2011 Apr 9. Eur J Pharmacol. 2011. PMID: 21497161
-
Arnicolide D: a multi-targeted anticancer sesquiterpene lactone-preclinical efficacy and mechanistic insights.Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6317-6336. doi: 10.1007/s00210-024-03095-7. Epub 2024 Apr 23. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38652277 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous